Kanpur: The first Indian Intranasal Intrasner Vaccine trial against Covid-19 is being developed by Bharat Biotech in collaboration with the Washington University Medical School in St.
Louis, began at Prakhar City Hospital on Tuesday.
Kanpur is the only center in the state where the intranasal vaccine trial against Covid is being carried out.
As many as 30 volunteers consisting of doctors, their family members and others were given the first dose of intranasal vaccines.
20 other people will be given this vaccine in the next few days.
It will after 28 days, the second dose of this vaccine will be given to these 50 volunteers.
All volunteers who were given nose vaccines were adults, the main investigator said for intranasal covid vaccines, Dr.
JS Kushwaha when talking to Toi.
He said that the vaccine dose given to healthy volunteers in this phase of the trial had been well tolerated and there were no serious side effects reported.
However, all volunteers are in observation.
Dr.
Kushwaha who gave a vaccine to the volunteers, while explaining how this vaccine was conveyed, said, “Two drops of Intrasal vaccine were put in every volunteer nostrils.
After a five-minute gap, two more drops were given in the same way.
In this way a total of eight Drops of vaccines are given to everyone.
Volunteers are then observed for each reaction for more than one hour before being allowed to continue home.
“He added,” the vaccine given today will now report after 28 days and the same procedure will be repeated.
” He also said that before the Intrasal vaccine administration for the second time, saliva and blood samples would be collected to study immunogenicity.
He also mentioned that if the intranasal vaccine received approval in the future, it would be a great discovery and also a big relief for people who were afraid to take vaccine doses through injection.
“Intrasal vaccines were dropped into a person’s nostrils and gradually slipped into the respiratory tract.
This vaccine dose is repeated after 28 days like Covaxin, which is given twice in the same period of time.
The vaccine will neutralize the virus in the nostrils itself and will not Let it penetrate deep into the respiratory tract, “said Dr.
Kushwaha to Ti.
He said that the two vaccine doses were given to volunteers, blood samples and saliva will be collected and sent to Bharat Biotech for antibody analysis.
“Until now, there is nothing in the world, Intranasal vaccines exist.
Americans also try to develop intranasal vaccines and so are we.
If this vaccine was developed, it would be a big breakthrough in the war against Covid-19,” said Dr.
Kushwaha.